Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
Sam Schulman(Thrombosis and Atherosclerosis Research Institute), Winfield S. Fisher(University of Alabama at Birmingham), Ulf Angerås(Sahlgrenska University Hospital), David Bergqvist(Uppsala University Hospital), Bengt O. Eriksson(Sahlgrenska University Hospital), Michael R. Lassen(Thrombosis and Atherosclerosis Research Institute)
Cited by 3,756
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k
Prevention of VTE in Orthopedic Surgery Patients
|CHEST Journal|2012|1.9k